Tessera Therapeutics
Jody Massey has a strong background in data analysis, with experience in the fields of genomics and cytogenetics. They started their career at BioReference Laboratories in 2008, where they worked as a Senior Cytogenetics Technologist until 2017. In 2018, they joined Integrated Genetics as a Genomic Data Analyst and stayed with the company until 2023. Most recently, Jody joined Tessera Therapeutics as a Lead Data Analyst in February 2023.
Jody Massey has attended Fitchburg State University but does not have a specified start or end year. Additionally, Jody has obtained a certification as a Cytogenetics Technologist from the American Society for Clinical Pathology (ASCP), but the specific month and year of obtaining the certification are not provided.
This person is not in the org chart
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.